V. APNA 12th Annual Clinical Psychopharmacology Institute

12th Annual Clinical Psychopharmacology Institute
From Cells to Community: Integrating Psychopharmacology into Nursing Practice

June 19-22, 2014
Hyatt Regency Reston

Registration rate ($395) includes online access to podcasts – no increase from 2013!
Attendance: 455
21.5 Continuing Nursing Education contact hours
Book provided to all attendees - I am Not Sick, I Don't Need Help! (keynote)

Objectives:

  1. Incorporate psychopharmacologic mental health nursing practice interventions that reflect the context of psychiatric illness from the cellular through the community level.
  2. Review evidence-based pharmacologic approaches related to the prescribing, administration, and monitoring of psychotropic medications for persons diagnosed with complex psychiatric disorders across their environments of care.
  3. Discuss clinical psychopharmacological issues for psychiatric mental health nurses and consumers relevant to the continuum of wellness and recovery.

Faculty/Topic:

Pre-Conference

Laura G. Leahy, DrNPc, APN, PMH-CNS/FNP – Conquering Clinical Conundrums: Psychopharmacology in the 21st Century

Conference Program

Markus Heilig, MD, PhD – (Keynote) Personalized Medicine Approaches to the Treatment of Alcohol Addiction
Xavier F. Amador, PhD - (Keynote) – "I am Not Sick, I Don't Need Help!" Research on Poor Insight and How We Can Help
Elizabeth Galik, MS, RN, PhD – Uncommon Complications in Using Psychotropic Medications with Older Adults
Joseph M. Holshoe, MSN, PMHNP-BC – Understanding Sleep and Antidepressants: Lessons from Research Literature and Clinical Practice
Susan E. Swedo, MD – PANDAS, CANs, Autism Spectrum Update
Christian J. Teter, PharmD, BCPP – Cannabinoids Overview: Medical Use, Abuse, Pharmacotherapy, and Assessment of Consequences
Sharon R. Katz, MSN, FPMH-APRN, CRNP – Collaborative Care: Organizing Treatment Options and Psychopharmacology in Integrated Mental Health Settings
Jessica M. Gill, PhD, RN – An Exemplar of the use of Genomics to Determine Pharmacological Agents to Treat Trauma-related Disorders
Barbara J. Limandri, PhD, PMHCNS-BC and Eric C. Arauz, MA, MLER – Consumer Perspectives on Medication: Continuing the Conversation
Mary Rosedale PhD, PMHNP-BC, NEA-BC – Treatment Choices in Neuromodulation vs Medication
Carrie Carretta, PhD, APN, AHN-BC, FPMHNP – Assessing, Prescribing, and Examining the Evidence through a Forensic Lens

Symposium Luncheon: Managing Bipolar Type I Depression: Maximizing Benefits, Minimizing Risks

Breakfast Product Theaters:

  • Misconceptions Related to Long-Acting Injectable use in Schizophrenia
  • Bipolar Depression: Presentation, Diagnosis and Treatment


2015 – New Location

13th Annual Clinical Psychopharmacology Institute – Planned for Nurses by Nurses
Hyatt Regency Baltimore Inner Harbor – June 12-14, 2015

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.